Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Capri Holdings
CPRI
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By product
See full
Accessories
55.8%
+0.7%
Footwear
24.6%
+0.4%
Apparel
12.8%
-4.5%
Other financials
Income statement
See full
Revenue
$796.0M
-3.7%
Gross profit
$516.0M
+4.2%
Operating income
$46.0M
+76.9%
Net income
-
+100%
EPS (diluted)
$0.00
+100%
Balance sheet
See full
Cash & equivalents
$135.0M
+26.2%
Total debt
$1.4B
-54.1%
Total equity
$80.0M
-78.3%
Total assets
$3.2B
-38.0%
Cash flow
See full
Operating cash flow
$202.0M
-34.6%
CapEx
$18.0M
+12.5%
Free cash flow
$183.0M
-36.2%
Valuation
See full
Market cap
$2.17B
+11.6%
Enterprise value
$3.45B
-23.5%
P/E
15.4×
—
P/S
0.6×
+0.1×
Profitability
See full
Gross margin
62.3%
+0.1pp
Operating margin
-0.2%
—
Net margin
4.1%
+2.1pp
FCF margin
14.5%
+10.2pp
Returns & leverage
See full
Return on equity
62.9%
+38.0pp
Debt / equity
17.8×
+9.3×
Current ratio
1.2×
+0.1×